製藥自動化市場規模、佔有率和成長分析（按給藥類型、自動化方法、最終用戶、應用和地區分類）—2026-2033年產業預測

預計到 2024 年，全球製藥自動化市場規模將達到 83.8 億美元，到 2025 年將達到 92.9 億美元，到 2033 年將達到 210.9 億美元，預測期（2026-2033 年）的複合年成長率為 10.8%。

全球藥房自動化產業正經歷著變革性的轉變，這主要得益於分析技術和軟體的進步。這些創新顯著提高了零售藥局的營運效率和盈利，實現了驚人的十倍提升。自動化不僅最大限度地減少了藥物浪費，還降低了單次用藥成本，簡化了藥師的工作流程，同時提高了病患滿意度。隨著處方藥和非處方藥價格的持續上漲，自動化為製藥公司提供了一條在不影響品質或安全性的前提下維持和擴大生產的途徑。其他優勢還包括更高的生產彈性和更快的生產線建設速度。彈性自動化、數位化、大量生產和個人化等當前產業趨勢正在蓬勃發展，進一步鞏固了自動化在當今製藥業中的關鍵作用。

推動全球製藥自動化市場發展的因素

全球製藥自動化市場的成長受多種關鍵因素驅動，其中包括機器人技術在製藥生產中日益普及。政府鼓勵產業發展的扶持政策也進一步推動了這個趨勢。此外，旨在提升效率和生產力的傳統生產設施升級改造投資顯著增加。加之消費者對安全、數位化生產流程的需求不斷成長，這些因素共同促進了製藥自動化的擴張，凸顯了該行業向更先進、更自動化解決方案的轉變。

限制全球製藥自動化市場的因素

新冠疫苗生產的巨大需求，以及物聯網技術在製藥生產中日益廣泛的應用，預計將為全球製藥自動化市場創造巨大的成長機會。這些因素將推動創新，提升營運效率，使企業能夠更好地適應不斷變化的產業需求。隨著自動化在維持生產流程的品質和速度方面變得愈發重要，市場有望受益於技術進步，從而提高整體生產效率和應對力市場波動的能力，最終形成更加激烈的競爭格局。

全球製藥自動化市場趨勢

受對先進技術日益成長的需求推動，藥房自動化市場正經歷顯著成長，這些技術旨在最大限度地減少用藥錯誤並提高營運效率。隨著醫療系統努力提升患者安全並簡化流程，自動化配藥系統、機器人和整合軟體解決方案的應用正在蓬勃發展。藥品生產和分銷的日益複雜化以及對監管合規性的日益重視進一步推動了這一趨勢。此外，人工智慧 (AI) 和機器學習的整合有望變革傳統做法，並為建立更有效率、更可靠的藥品供應鏈鋪平道路。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管環境

全球製藥自動化市場規模（以交付方式分類）及複合年成長率（2026-2033 年）

• 硬體
• 軟體
• 服務

全球製藥自動化市場規模（按自動化方式和複合年成長率分類）（2026-2033 年）

• 全自動系統
• 半自動系統

全球製藥自動化市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 製藥公司
• 研究所
• 契約製造組織（CMO）
• 受託研究機構（CRO）

全球製藥自動化市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 藥物發現
• 藥物研發
• 臨床試驗
• 製造業
• 包裝
• 品管

全球製藥自動化市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Becton, Dickinson and Company（USA）
• Baxter International Inc.（USA）
• Siemens Healthineers（Germany）
• GE Healthcare（USA）
• Omnicell, Inc.（USA）
• Swisslog Healthcare（Switzerland）
• Capsa Healthcare（USA）
• Parata Systems（USA）
• ARxIUM（Canada）
• ScriptPro LLC（USA）
• Yuyama Co., Ltd.（Japan）
• McKesson Corporation（USA）
• Pearson Medical Technologies（USA）
• Accu-Chart Plus Healthcare Systems（USA）
• NewIcon（Finland）
• AlixaRx（USA）
• KUKA AG（Germany）
• TOSHO Inc.（Japan）
• Cerner Corporation（USA）

結論與建議

Global Pharmaceutical Automation Market size was valued at USD 8.38 Billion in 2024 and is poised to grow from USD 9.29 Billion in 2025 to USD 21.09 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The global pharmaceutical automation landscape is experiencing a transformative shift, primarily driven by advancements in analytics and software. This innovation is dramatically enhancing operational efficiency and profitability within retail pharmacies, achieving an impressive tenfold improvement. Automation not only minimizes medication waste but also decreases per-dose costs, all while streamlining workflow for pharmacists and elevating patient satisfaction. As the prices of prescription and over-the-counter medications continue to rise, automation offers pharmaceutical companies a pathway to sustain or boost production without compromising quality or safety. Additionally, the sector benefits from increased production agility and rapid assembly of production lines. Current industry trends such as flexible automation, digitalization, batch production, and personalization have gained momentum, reinforcing the vital role of automation in today's pharmaceutical landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Automation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Automation Market Segments Analysis

Global Pharmaceutical Automation Market is segmented by Offering, Mode of Automation, End User, Application and region. Based on Offering, the market is segmented into Hardware, Software and Services. Based on Mode of Automation, the market is segmented into Fully-Automated Systems and Semi-Automated Systems. Based on End User, the market is segmented into Pharmaceutical Companies, Research Laboratories, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on Application, the market is segmented into Drug Discovery, Drug Development, Clinical Trials, Manufacturing, Packaging and Quality Control. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Automation Market

The growth of the Global Pharmaceutical Automation market is driven by several key factors, including the increasing integration of robotics in pharmaceutical manufacturing. Supportive government initiatives aimed at fostering industrial advancement further bolster this trend. Additionally, there is a notable surge in investments focused on upgrading conventional production facilities to enhance efficiency and productivity. Coupled with a growing consumer demand for safe and digitized manufacturing processes, these elements collectively contribute to the expanding landscape of pharmaceutical automation, highlighting a shift towards more advanced and automated solutions within the industry.

Restraints in the Global Pharmaceutical Automation Market

The significant demand for COVID-19 vaccine production, coupled with the increasing integration of IoT technology in pharmaceutical manufacturing, is expected to create considerable opportunities for growth within the Global Pharmaceutical Automation market. These factors are likely to drive innovation and enhance operational efficiency, allowing companies to adapt to evolving industry needs. As automation becomes more essential for maintaining quality and speed in production processes, the market is poised to benefit from advancements in technology that improve overall productivity and responsiveness to market fluctuations, ultimately facilitating a stronger competitive landscape.

Market Trends of the Global Pharmaceutical Automation Market

The global pharmaceutical automation market is experiencing significant growth driven by an increasing demand for advanced technologies that minimize medication errors and enhance operational efficiency. As healthcare systems seek to improve patient safety and streamline processes, the adoption of automated dispensing systems, robotics, and integrated software solutions is surging. This trend is further bolstered by the rising complexity of pharmaceutical manufacturing and distribution, alongside the growing emphasis on regulatory compliance. Additionally, the integration of artificial intelligence and machine learning is set to transform traditional practices, paving the way for a more efficient and reliable pharmaceutical supply chain.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Automation Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Hardware
• Software
• Services

Global Pharmaceutical Automation Market Size by Mode of Automation & CAGR (2026-2033)

• Market Overview
• Fully-Automated Systems
• Semi-Automated Systems

Global Pharmaceutical Automation Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Research Laboratories
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Automation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Drug Discovery
• Drug Development
• Clinical Trials
• Manufacturing
• Packaging
• Quality Control

Global Pharmaceutical Automation Market Size & CAGR (2026-2033)

• North America (Offering, Mode of Automation, End User, Application)
  • US
  • Canada
• Europe (Offering, Mode of Automation, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Mode of Automation, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Mode of Automation, End User, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Mode of Automation, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omnicell, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Swisslog Healthcare (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsa Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parata Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARxIUM (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScriptPro LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yuyama Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pearson Medical Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accu-Chart Plus Healthcare Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NewIcon (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AlixaRx (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KUKA AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TOSHO Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations